213 related articles for article (PubMed ID: 37494846)
1. Transcriptional intra-tumour heterogeneity predicted by deep learning in routine breast histopathology slides provides independent prognostic information.
Wang Y; Ali MA; Vallon-Christersson J; Humphreys K; Hartman J; Rantalainen M
Eur J Cancer; 2023 Sep; 191():112953. PubMed ID: 37494846
[TBL] [Abstract][Full Text] [Related]
2. Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer.
Sharma A; Weitz P; Wang Y; Liu B; Vallon-Christersson J; Hartman J; Rantalainen M
Breast Cancer Res; 2024 Jan; 26(1):17. PubMed ID: 38287342
[TBL] [Abstract][Full Text] [Related]
3. Improved breast cancer histological grading using deep learning.
Wang Y; Acs B; Robertson S; Liu B; Solorzano L; Wählby C; Hartman J; Rantalainen M
Ann Oncol; 2022 Jan; 33(1):89-98. PubMed ID: 34756513
[TBL] [Abstract][Full Text] [Related]
4. A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Prat A; Guarneri V; Paré L; Griguolo G; Pascual T; Dieci MV; Chic N; González-Farré B; Frassoldati A; Sanfeliu E; Cejalvo JM; Muñoz M; Bisagni G; Brasó-Maristany F; Urso L; Vidal M; Brandes AA; Adamo B; Musolino A; Miglietta F; Conte B; Oliveira M; Saura C; Pernas S; Alarcón J; Llombart-Cussac A; Cortés J; Manso L; López R; Ciruelos E; Schettini F; Villagrasa P; Carey LA; Perou CM; Piacentini F; D'Amico R; Tagliafico E; Parker JS; Conte P
Lancet Oncol; 2020 Nov; 21(11):1455-1464. PubMed ID: 33152285
[TBL] [Abstract][Full Text] [Related]
5. Radiographical assessment of tumour stroma and treatment outcomes using deep learning: a retrospective, multicohort study.
Jiang Y; Liang X; Han Z; Wang W; Xi S; Li T; Chen C; Yuan Q; Li N; Yu J; Xie Y; Xu Y; Zhou Z; Poultsides GA; Li G; Li R
Lancet Digit Health; 2021 Jun; 3(6):e371-e382. PubMed ID: 34045003
[TBL] [Abstract][Full Text] [Related]
6. A deep learning image-based intrinsic molecular subtype classifier of breast tumors reveals tumor heterogeneity that may affect survival.
Jaber MI; Song B; Taylor C; Vaske CJ; Benz SC; Rabizadeh S; Soon-Shiong P; Szeto CW
Breast Cancer Res; 2020 Jan; 22(1):12. PubMed ID: 31992350
[TBL] [Abstract][Full Text] [Related]
7. Deep learning radiopathomics based on preoperative US images and biopsy whole slide images can distinguish between luminal and non-luminal tumors in early-stage breast cancers.
Huang Y; Yao Z; Li L; Mao R; Huang W; Hu Z; Hu Y; Wang Y; Guo R; Tang X; Yang L; Wang Y; Luo R; Yu J; Zhou J
EBioMedicine; 2023 Aug; 94():104706. PubMed ID: 37478528
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral heterogeneity of Ki67 proliferation index outperforms conventional immunohistochemistry prognostic factors in estrogen receptor-positive HER2-negative breast cancer.
Zilenaite-Petrulaitiene D; Rasmusson A; Besusparis J; Valkiuniene RB; Augulis R; Laurinaviciene A; Plancoulaine B; Petkevicius L; Laurinavicius A
Virchows Arch; 2024 Jan; ():. PubMed ID: 38217716
[TBL] [Abstract][Full Text] [Related]
9. Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR
Hu J; Lv H; Zhao S; Lin CJ; Su GH; Shao ZM
J Thorac Dis; 2023 May; 15(5):2528-2543. PubMed ID: 37324098
[TBL] [Abstract][Full Text] [Related]
10.
Mondol RK; Millar EKA; Graham PH; Browne L; Sowmya A; Meijering E
Cancers (Basel); 2023 Apr; 15(9):. PubMed ID: 37174035
[TBL] [Abstract][Full Text] [Related]
11. Overcoming intratumoural heterogeneity for reproducible molecular risk stratification: a case study in advanced kidney cancer.
Lubbock ALR; Stewart GD; O'Mahony FC; Laird A; Mullen P; O'Donnell M; Powles T; Harrison DJ; Overton IM
BMC Med; 2017 Jun; 15(1):118. PubMed ID: 28648142
[TBL] [Abstract][Full Text] [Related]
12. Deep learning provides a new computed tomography-based prognostic biomarker for recurrence prediction in high-grade serous ovarian cancer.
Wang S; Liu Z; Rong Y; Zhou B; Bai Y; Wei W; Wei W; Wang M; Guo Y; Tian J
Radiother Oncol; 2019 Mar; 132():171-177. PubMed ID: 30392780
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up.
Ohnstad HO; Borgen E; Falk RS; Lien TG; Aaserud M; Sveli MAT; Kyte JA; Kristensen VN; Geitvik GA; Schlichting E; Wist EA; Sørlie T; Russnes HG; Naume B
Breast Cancer Res; 2017 Nov; 19(1):120. PubMed ID: 29137653
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of different molecular typing methods and immune status based on RNA sequencing in HR-positive and HER2-negative early-stage breast cancer.
Ren X; Song Y; Zhang Y; Wu H; Chen L; Pang J; Zhou L; Shen S; Liang Z
BMC Cancer; 2022 May; 22(1):548. PubMed ID: 35568835
[TBL] [Abstract][Full Text] [Related]
16. Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images.
Wetstein SC; de Jong VMT; Stathonikos N; Opdam M; Dackus GMHE; Pluim JPW; van Diest PJ; Veta M
Sci Rep; 2022 Sep; 12(1):15102. PubMed ID: 36068311
[TBL] [Abstract][Full Text] [Related]
17. Histological grade provides significant prognostic information in addition to breast cancer subtypes defined according to St Gallen 2013.
Ehinger A; Malmström P; Bendahl PO; Elston CW; Falck AK; Forsare C; Grabau D; Rydén L; Stål O; Fernö M;
Acta Oncol; 2017 Jan; 56(1):68-74. PubMed ID: 27762648
[TBL] [Abstract][Full Text] [Related]
18. BCR-Net: A deep learning framework to predict breast cancer recurrence from histopathology images.
Su Z; Niazi MKK; Tavolara TE; Niu S; Tozbikian GH; Wesolowski R; Gurcan MN
PLoS One; 2023; 18(4):e0283562. PubMed ID: 37014891
[TBL] [Abstract][Full Text] [Related]
19. Deep-Learning-Based Characterization of Tumor-Infiltrating Lymphocytes in Breast Cancers From Histopathology Images and Multiomics Data.
Lu Z; Xu S; Shao W; Wu Y; Zhang J; Han Z; Feng Q; Huang K
JCO Clin Cancer Inform; 2020 May; 4():480-490. PubMed ID: 32453636
[TBL] [Abstract][Full Text] [Related]
20. Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer.
Rakha EA; Agarwal D; Green AR; Ashankyty I; Ellis IO; Ball G; Alaskandarany MA
Histopathology; 2017 Mar; 70(4):622-631. PubMed ID: 27782306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
